K Seki Selected Research

K Seki Research Topics

Disease

8	Neoplasms (Cancer) 01/2009 - 06/2000
3	Neoplasm Metastasis (Metastasis) 05/2001 - 07/2000
2	Hepatocellular Carcinoma (Hepatoma) 07/2014 - 07/2000
2	Adenocarcinoma 01/2009 - 07/2001
2	Hypertension (High Blood Pressure) 02/2006 - 03/2005
1	COVID-19 01/2021
1	Shock 11/2015
1	Infarction (Infarctions) 01/2015
1	Stroke (Strokes) 01/2015
1	Cleft Lip (Harelip) 09/2010
1	Female Genital Diseases 01/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2009
1	Birth Weight (Birth Weights) 03/2007
1	Necrosis 01/2007
1	Bacterial Infections (Bacterial Infection) 01/2007
1	Staphylococcal Infections 01/2007
1	Mouth Neoplasms (Oral Cancer) 09/2005
1	Squamous Cell Carcinoma of Head and Neck 09/2005
1	Stomatitis 09/2005
1	Nodular Nonsuppurative Panniculitis (Weber-Christian Disease) 06/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2005
1	Essential Hypertension 03/2005
1	Infertility (Sterility) 08/2004
1	Mucositis 11/2002
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2002
1	Ovarian Epithelial Carcinoma 01/2002
1	Human Influenza (Influenza) 09/2001
1	Diarrhea 08/2001
1	Hydatidiform Mole (Molar Pregnancy) 06/2001
1	Subdural Hematoma (Subdural Hemorrhage) 05/2001
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 03/2001
1	Trophoblastic Neoplasms (Trophoblastic Tumor) 07/2000
1	Chronic Hepatitis C 07/2000
1	Thrombocytopenia (Thrombopenia) 07/2000
1	Leukopenia 07/2000
1	Myxoid Liposarcoma 06/2000
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2000
1	Osteosarcoma (Osteogenic Sarcoma) 01/2000
1	Muscular Diseases (Myopathy) 01/2000

Drug/Important Bio-Agent (IBA)

2	Cisplatin (Platino)FDA LinkGeneric 07/2014 - 01/2000
2	CytokinesIBA 01/2007 - 09/2001
2	Estrogens (Estrogen)FDA Link 02/2006 - 06/2000
2	Carboplatin (JM8)FDA LinkGeneric 11/2002 - 08/2001
2	Etoposide (VP 16)FDA LinkGeneric 03/2001 - 07/2000
2	Dactinomycin (Actinomycin)FDA LinkGeneric 03/2001 - 07/2000
2	Methotrexate (Mexate)FDA LinkGeneric 03/2001 - 07/2000
1	Colchicine FDA LinkGeneric 01/2021
1	IonsIBA 11/2015
1	N(6)-allyl-N(6)-cyclohexyladenosineIBA 01/2015
1	CarbohydratesIBA 01/2009
1	EnzymesIBA 01/2009
1	ImmunosorbentsIBA 01/2009
1	squamous cell carcinoma-related antigenIBA 01/2009
1	AntigensIBA 01/2009
1	methyl 4-azidophenylacetimidate (APAI)IBA 03/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007
1	Interleukin-8 (Interleukin 8)IBA 01/2007
1	Cell Adhesion MoleculesIBA 01/2007
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2005
1	SteroidsIBA 06/2005
1	Antihypertensive Agents (Antihypertensives)IBA 03/2005
1	Ethanol (Ethyl Alcohol)IBA 08/2004
1	EndotoxinsIBA 08/2004
1	Docetaxel (Taxotere)FDA Link 11/2002
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2001
1	HLA-A*02:01 antigenIBA 09/2001
1	Peptides (Polypeptides)IBA 09/2001
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2001
1	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2001
1	Messenger RNA (mRNA)IBA 07/2001
1	RNA (Ribonucleic Acid)IBA 07/2000
1	InterferonsIBA 07/2000
1	Alanine Transaminase (SGPT)IBA 07/2000
1	Vincristine (Oncovin)FDA LinkGeneric 07/2000
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2000
1	DNA (Deoxyribonucleic Acid)IBA 06/2000
1	Monoclonal AntibodiesIBA 06/2000
1	Transcription Factor CHOPIBA 06/2000
1	Pharmaceutical PreparationsIBA 01/2000
1	Caspase 8 (Caspase-8)IBA 01/2000
1	CaspasesIBA 01/2000

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 07/2014 - 01/2000
4	Therapeutics 03/2005 - 01/2000
2	Radiotherapy 09/2005 - 11/2002
2	Combination Drug Therapy (Combination Chemotherapy) 08/2001 - 07/2000
1	Bone Transplantation (Bone Grafting) 09/2010
1	Chronotherapy 10/2005
1	Chemoradiotherapy 09/2005
1	Intravenous Administration 01/2002
1	Adjuvant Chemotherapy 01/2002
1	Maintenance Chemotherapy 01/2002
1	Immunotherapy 09/2001
1	Lymph Node Excision (Lymph Node Dissection) 05/2001
1	Craniotomy 05/2001
1	Hysterectomy 03/2001
1	Pancreaticoduodenectomy 01/2001
1	MEA regimen 07/2000
1	Aftercare (After-Treatment) 07/2000
1	Hyperbaric Oxygenation 01/2000